News

Feb 21, 2020

PHARMA Support for Control of Novel Coronavirus in China

Feb 14, 2020

HD We received a high grade of A- in CDP climate change

Feb 6, 2020

HD 【Presentation】Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2020

Feb 6, 2020

HD Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2020

Jan 9, 2020

PHARMA Meiji and HUYABIO Enter into Exclusive Distribution, License and Collaboration Agreement of HBI-8000 for ATLL and PTCL Treatment in Japan and Certain Asian Countries

Jan 7, 2020

HD We updated Standard Table

Jan 7, 2020

PHARMA Meiji Seika Pharma and Kadmon Enter into Strategic Partnership to Develop and Commercialize KD025 for GVHD treatment in Japan and Asian Countries